Stay updated on Charles River Laboratories Press Releases
Sign up to get notified when there's something new on the Charles River Laboratories Press Releases page.
Latest updates to the Charles River Laboratories Press Releases page
- ChecktodayChange DetectedCharles River has announced the launch of a new Retrogenix® Non-Human Protein Library and scheduled its third-quarter 2024 earnings release and conference call.SummaryDifference3%
- Check8 days agoChange DetectedCharles River has announced its participation in Neuroscience 2024, highlighting their translational expertise.SummaryDifference1%
- Check15 days agoChange DetectedCharles River and Lundbeck have entered an agreement to utilize AI-Powered Logica® for advancing the discovery of novel drugs targeting neurological diseases.SummaryDifference3%
- Check22 days agoNo Change Detected
- Check93 days agoChange DetectedThe website has added information about Charles River Laboratories scheduling their second-quarter 2024 earnings release and conference call at $227.31 as of 07/16/24 4:10 pm EDT.SummaryDifference3%
- Check101 days agoChange DetectedCharles River will now perform Plasmid Manufacturing for AAVantgarde, with a price increase of $2.80 (+1.40%) as of 07/08/24 4:10 pm EDT.SummaryDifference2%
- Check114 days agoChange DetectedThe value on the web page has changed to '06/25/24 Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus.' This change represents a new collaboration announcement between Charles River Laboratories and the Gates Institute at the University of Colorado Anschutz Medical Campus.SummaryDifference5%
Stay in the know with updates to Charles River Laboratories Press Releases
Enter your email address, and we'll notify you when there's something new on the Charles River Laboratories Press Releases page.